碱性成纤维细胞生长因子研究进展

碱性成纤维细胞生长因子是一种在体内分布广泛、生理功能重要的生长因子,本文综合讨论了其家族成员、分子结构、生物学功能、作用机理和研究趋向等问题。     

碱性成纤维细胞生长因子

综述了近年来碱性纤维细胞生长因子（ｂＦＧＦ）的研究进展,重点介绍了ｂＦＧＦ的两类受体及其在信号传递过程中的作用,讨论了ｂＦＧＦ的基因结构及表达调控机制,阐述了ＢＦＧＦ的生物学功能。     

碱性成纤维细胞生长因子的研究进展

碱性成纤维细胞生长因子是一种多肽细胞生长因子,具有广泛的生理功能。碱性成纤维细胞生长因子的研究近年来取得了迅速发展,尤其是基因的表达及临床应用等方面。本文就该生长因子基因的克隆和表达、生物功能及临床应用研究进展作一概述。     

碱性成纤维细胞生长因子与中枢神经元的功能

本文主要介绍bFGF在中枢神经元的多种功能及应用前景。bFGF作为多功能生长因子不仅可促进神经元存活,轴突生长,再生,保护神经元避免毒物损伤,而且还可促进移植神经元存活,调节神经元突触传递功能,发挥宽刘经递质,调质作用等,并具有明显的神经保护作用。为此bFGF可能在治疗进行性神经退行性疾病中起重要作用,如治疗阿尔茨海默病,帕金森病等。     

碱性成纤维细胞生长因子与肿瘤

碱性成纤维细胞生长因子（basic fibroblast growth factor,bFGF) 作为多种细胞的致裂源,与肿瘤的关系近几年来受到关注,本文概述了有关bFGF与肿瘤关系的研究进展。     

碱性成纤维细胞生长因子促进神经损伤修复的研究进展

碱性成纤维细胞生长因子(basic fibroblast growth factor,b FGF)是成纤维细胞生长因子家族(FGFs)的成员之一。它是哺乳动物和人体中一种非常微量的活性物质,因其具有广泛的生理功能和重要的临床应用价值受到了国内外学者的高度重视。b FGF生物活性的多效性以及神经营养的广谱性,为其从基础走向临床提供了保证。而b FGF如何发挥神经损伤修复作用的功能和机制,仍有待进一步的发现及研究,这也是目前国内外探索和开发b FGF新临床药物的研究热点之一。针对b FGF的生物学特点及其在神经损伤修复中的功能,特别是在中枢神经系统和外周神经系统疾病中的研究进展进行了综述。     

碱性成纤维细胞生长因子在苜蓿中的表达

为了降低bFGF(basic fibroblast growth factor)的生产成本,结合植物生物反应器的优点,就bFGF在转基因苜蓿中的表达进行了探索.将bFGF插入植物表达载体pBⅡ21中,获得了含有bFGF基因的植物表达pBIcbFGF,再将pBIcbFGF利用冻融法转到农杆菌中.利用农杆菌介导法将基因转化保定苜蓿,转基因苜蓿在TM-1培养基+20 mg/L卡那霉素(Kan)+200 mg/L特美汀(Tim)中诱导分化,在生根培养基中生根,获得再生植株.再生植株通过PCR检测、RT-PCR及Western blot证实外源基因已经在苜蓿中成功表达.获得含有目的蛋白的阳性植株.为苜蓿作为植物生物反应器生产bFGF奠定了理论及技术基础.     

碱性成纤维细胞生长因子制剂稳定性的研究

本研究通过MTT法检测bFGF的活性,研究了不同温度下四种制剂中bFGF的稳定性。结果得到,bFGF在2．0mol／L NaCl,0．05mol／L PB溶液(pH7.2)中,-20℃下贮藏6个月活性没有明显的下降;bFGF水剂贮藏在4℃下,bFGF活性随贮藏时间延长逐步下降,单位活性bFGF用量由0.4ng／mL下降为0．9ng／mL,室温下bFGF的活性丧失快于4℃下贮藏,3个月后bFGF单位活性用量由0．4ng／mL下降为1．0ng／mL。而乳霜剂和胶束剂中的bFGF在两种温度下贮藏一个月后,均检测不到对细胞生长的刺激作用。说明低温有利于制剂中bFGF的稳定,乳霜剂和胶束剂中的bFGF稳定性不好。     

成纤维细胞生长因子研究进展

成纤维细胞生长因子（ＦＧＦ）家族至少有七个成员,有些成员是原癌基因的产物。它们对多种细胞的生长与分化具有调节作用。该家族存在两类受体,高亲和力受体具有酷氨酸蛋白激酶活性,低亲和力受体为肝素受体。ＦＧＦ对神经生长因子、血小板衍生生长因子的表达有一定调控作用。     

Enhanced fibronectin-mediated cell adhesion of human osteoblast by fibroblast growth factor, FGF-2

Using specific recombinant human fibronectin peptide (hFNIII9-10) that contains the binding site for integrin, we found that the fibroblast growth factor, FGF-2, enhances fibronectin-mediated adhesion in human osteoblast-like MG63 cells. The mechanism of the synergistic adhesion was due to the activation of extracellular-regulated kinase (ERK)-type MAPK upon interaction of integrin to hFNIII9-10 and its downstream activation of signaling pathways.     

Direct interaction between CCN family protein 2 and fibroblast growth factor 1

In an attempt to find out a new molecular counterpart of CCN family protein 2 (CCN2), a matricellular protein with multiple functions, we performed an interactome analysis and found fibroblast growth factor (FGF) -1 as one of the candidates. Solid-phase binding assay indicated specific binding between CCN2 and FGF-1. This binding was also confirmed by surface plasmon resonance (SPR) analysis that revealed a dissociation constant (Kd) of 3.98 nM indicating strong molecular interaction between the two. RNA analysis suggested that both FGF-1 and CCN2 could be produced by chondrocytes and thus their interaction in the cartilage is possible. These findings for the first time indicate the direct interaction of CCN2 and FGF-1 and suggest the co-presence of these molecules in the cartilage microenvironment. CCN2 is a well-known promoter of cartilage development and regeneration, whereas the physiological and pathological role of FGF-1 in cartilage mostly remains unclear. Biological role of FGF-1 itself in cartilage is also suspected.     

Basic fibroblast growth factor in Alzheimer's disease

We have examined the presence of basic fibroblast growth factor (FGF) in normal and in Alzheimer brains, studied the distribution of the mitogen by immunohistochemical techniques, measured the quantities of growth factor in selected areas of the brain (Brodmann areas 10/11 and 20/21), characterized the molecular forms by Western blotting and determined its sites of synthesis by in situ hybridization. Although the same molecular forms of basic FGF are found in control and Alzheimer brains, basic FGF is increased in the brains of Alzheimer's patients. Furthermore, basic FGF is not distributed in an identical fashion to normal and Alzheimer brains, but is found in association with the lesions that characterize this disease. In normal controls (n = 5), basic FGF was found to be widely distributed throughout the three brain regions examined (prefrontal cortex, hippocampus, and hypothalamus). Immunoreactivity was observed within astrocytes in both the grey and white matter, as well as within neuronal perikarya. Brain tissues that were obtained from Alzheimer patients (N = 4) showed a substantial increase in the overall specific staining of astrocytes and neurons, particularly in areas of reactive gliosis. Focal concentration of immunoreactive basic FGF was evident within the neuritic plaques, and could be clearly seen in association with the neurofibrillary tangles present within neuronal perikarya. The possibility that basic FGF expression in the CNS is linked to the pathogenesis of the disease is discussed.     

Immunolocalization of fibroblast growth factor-2 (FGF-2) in the developing root and supporting structures of the murine tooth

Summary Epithelio–mesenchymal interactions are active during the development of the root of the tooth and are regulated by a variety of growth factors, such as fibroblast growth factors. FGF-2, 3, 4, and 8 have all been shown to play a role in the development of the crown of the tooth, but less is known about the factors that govern root formation, particularly FGF-2. The aim of this study was thus to elucidate the spatial and temporal expression of FGF-2 in the root of the developing tooth, as this growth factor is believed to be a mediator of epithelio–mesenchymal interactions. Parasagittal sections of the maxillary and mandibular arches of post-natal mice were utilized and the roots of the molar teeth were studied. Immunocytochemistry utilizing an antibody to FGF-2 was performed on sections of teeth at various stages of development. Intense immunostaining for FGF-2 was observed in differentiating odontoblasts at the apical end of the tooth and in the furcation zone of the developing root at all the stages examined. FGF-2 localization was also observed in cementoblasts on post-natal days 16, 20 and 24. The pattern of localization of FGF-2 in the developing root suggests that this growth factor may participate in the signaling network associated with root development.     

The epidermal growth factor.

Epidermal growth factor (EGF) is a single polypeptide of 53 amino acid residues which is involved in the regulation of cell proliferation. Egf exerts its effects in the target cells by binding to the plasma membrane located EGF receptor. The EGF receptor is a transmembrane protein tyrosine kinase. Binding of EGF to the receptor causes activation of the kinase and subsequently receptor autophosphorylation. The autophosphorylation is essential for the interaction of the receptor with its substrates. These bind to the receptor by the so-called SH2 domains. The signal transduction pathways activated by EGF include the phosphatidylinositol pathway, leading to activation of protein kinase C and to increase in the intracellular Ca2+ concentration, and to the ras pathway leading to MAP kinase activation. Recently the cytoplasm has been implicated as playing an important role in EGF induced signal transduction. The EGF receptor has been demonstrated to be an actin-binding protein. In addition EGF causes a rapid actin depolymerisation and the formation of membrane ruffles. In particular these membrane ruffles have been shown to act as the first site of signal transduction after EGF binding, and thus may be considered as signal transduction structures. Finally evidence has been presented suggesting a positive role for EGF and/or the receptor in the nucleus.     

Overexpression in Escherichia coli and purification of human fibroblast growth factor (FGF-2)

Basic fibroblast growth factor (FGF-2) is a member of a large family of structurally related proteins that affect the growth, differentiation, migration, and survival of many cell types. The human FGF-2 gene (encoding residues 1–155) was synthesized by PCR from 20 oligonucleotides and cloned into plasmid pET-32a. A high expression level (1 g/liter) of a fused protein thioredoxin/FGF-2 was achieved in Escherichia coli strain BL21(DE3). The fusion protein was purified from the soluble fraction of cytoplasmic proteins on a Ni-NTA agarose column. After cleavage of the thioredoxin/FGF-2 fusion with recombinant human enteropeptidase light chain, the target protein FGF-2 was purified on a heparin-Sepharose column. The yield of FGF-2 without N- and C-terminal tags and with high activity was 100 mg per liter of cell culture. Mutations C78S and C96S in the amino acid sequence of the protein decreased FGF-2 dimer formation without affecting its solubility and biological activity.     

Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin

The sulfated regions in heparan sulfate and heparin are known to affect fibroblast growth factor (FGF) function. We have studied the mechanism whereby heparin directs FGF-2-induced FGF receptor-1 (FGFR-1) signal transduction. FGF-2 alone stimulated maximal phosphorylation of Src homology domain 2 tyrosine phosphatase (SHP-2) and the adaptor molecule Crk, in heparan sulfate-deficient Chinese hamster ovary (CHO) 677 cells expressing FGFR-1. In contrast, for phospholipase Cgamma(1) (PLCgamma(1)) and the adaptor molecule Shb to be maximally tyrosine-phosphorylated, cells had to be stimulated with both FGF-2 and heparin (100 ng/ml). Tyrosine residues 463 in the juxtamembrane domain and 766 in the C-terminal tail in FGFR-1 are known to bind Crk and PLCgamma(1), respectively. Analysis of tryptic phosphopeptide maps of FGFR-1 from cells stimulated with FGF-2 alone and FGF-2 together with heparin showed that FGF-2 alone stimulated a several-fold increase in tyrosine 463 in the juxtamembrane domain. In contrast, heparin had to be included in order for tyrosine 766 to be phosphorylated to the same fold level. Our data imply that tyrosine 463 is phosphorylated and able to transduce signals in response to FGF-2 treatment alone; furthermore, we suggest that FGFR-1 dimerization/kinase activation is stabilized by heparin.